Previous close | 35.51 |
Open | 34.00 |
Bid | 27.64 x 2200 |
Ask | 27.72 x 1100 |
Day's range | 26.03 - 28.44 |
52-week range | 26.03 - 109.52 |
Volume | |
Avg. volume | 392,461 |
Market cap | 306.242M |
Beta (5Y monthly) | N/A |
PE ratio (TTM) | 3.08 |
EPS (TTM) | N/A |
Earnings date | N/A |
Forward dividend & yield | 6.60 (18.59%) |
Ex-dividend date | 18 Sept 2023 |
1y target est | N/A |
Shares of wellness company Medifast (NYSE:MED) fell 26.8% in the morning session after the company reported first quarter results that narrowly topped analysts' revenue expectations. However, revenue declined 49% in absolute terms, primarily driven by a decline in active earning OPTAVIA Coaches as well as lower Coach productivity. The company also called out a $9.1 million headwind due to timing differences from changes to sales order terms. Looking ahead, guidance was weak. The company's revenu
Despite a significant revenue drop, Medifast focuses on improved gross margins and strategic marketing investments to bolster future growth.